Goldman Sachs’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-507,400
Closed -$1.7M 7327
2016
Q3
$1.7M Buy
507,400
+118,800
+31% +$377K ﹤0.01% 3966
2016
Q2
$1.22M Sell
388,600
-223,600
-37% -$746K ﹤0.01% 4027
2016
Q1
$2.04M Buy
612,200
+597,100
+3,954% +$1.86M ﹤0.01% 3447
2015
Q4
$53K Buy
15,100
+6,000
+66% +$25.1K ﹤0.01% 6521
2015
Q3
$46K Buy
9,100
+8,100
+810% +$46.4K ﹤0.01% 6826
2015
Q2
$6K Sell
1,000
-2,200
-69% -$14.7K ﹤0.01% 7194
2015
Q1
$23K Sell
3,200
-305,400
-99% -$2.21M ﹤0.01% 6886
2014
Q4
$2.38M Sell
308,600
-151,800
-33% -$1.2M ﹤0.01% 3673
2014
Q3
$3.44M Buy
460,400
+450,900
+4,746% +$4.19M ﹤0.01% 3387
2014
Q2
$92K Sell
9,500
-1,700
-15% -$15.2K ﹤0.01% 6587
2014
Q1
$93K Sell
11,200
-1,800
-14% -$15.4K ﹤0.01% 6417
2013
Q4
$110K Buy
13,000
+6,700
+106% +$56.5K ﹤0.01% 6243
2013
Q3
$50K Sell
6,300
-8,300
-57% -$66.7K ﹤0.01% 6309
2013
Q2
$113K Buy
+14,600
New +$114K ﹤0.01% 5840

Other funds holding PDLI